C1 inhibitor haegerda
Ended Awarded
- Contract number
- 36C24821N0834
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $87,208
Award facts
- Contract value 100% obligated
- $87,207.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order awarded by the Veterans Integrated Service Network 8 (VISN 8), part of the U.S. Department of Veterans Affairs (VA), to CSL Behring L.L.C. The contract, which has a ceiling value of $87,207.54, is for the procurement of HAEGARDA, a C1 inhibitor medication used to treat hereditary angioedema. The delivery order was issued under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a larger ceiling value of $201,482,280 and is valid through September 2026. The contract does not have a set-aside designation, reflecting CSL Behring's status as a large, foreign-owned for-profit organization. This delivery order is part of the VA's efforts to provide critical pharmaceutical treatments to veterans through its regional medical facilities.
Quick answers
Who was awarded contract 36C24821N0834?
36C24821N0834 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 8 (Veterans Health Administration) on July 22, 2021.
How much is contract 36C24821N0834 worth?
The government has obligated $87,208 on 36C24821N0834.
Is contract 36C24821N0834 an order under another contract?
Yes. 36C24821N0834 is a delivery order under V797D50358, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24821N0834 competed?
The extent of competition for 36C24821N0834 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award